Family history of dementia does not influence the progression of Alzheimer's disease at two years: Results from the REAL.FR Study

American Journal of Alzheimer's Disease and other Dementias

Volumn 21, Issue 2, 2006, Pages 131-136

  Cortes, Frédéric ^a   Gillette Guyonnet, Sophie ^a   Nourhashemi, Fati ^a   Christelle, Cantet ^a   Vellas, Bruno ^a  

^a Service Med Interne Gerontol Clin   (France)

Author keywords

Alzheimer's disease; Family history of dementia; Progression

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DETERIORATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MULTICENTER STUDY; NUTRITION; OUTCOME ASSESSMENT; RELATIVE; STATISTICAL ANALYSIS;

EID: 33645794193     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/153331750602100214     Document Type: Article

References (23)

1. Ott A, Breteler MM, van Harskamp F, et al.: Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. Br Med J. 1995; 310: 970-973.
2. Poirier J, Davignon J, Bouthillier D, et al.: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993; 342: 697-699.
3. Saunders AM, Schmader K, Breitner JC, et al: Apolipoprotein E ε 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 1993; 342: 710-711.
4. van Duijn CM, Clayton D, Chandra V, et al.: Familial aggregation of Alzheimer's disease and related disorders: a collaborative reanalysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991; 20(Suppl 2): S13-S20.
5. Huang W, Qiu C, von Strauss E, et al.: APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Arch Neurol. 2004; 61: 1930-1934.
6. Stern RG, Mohs RC, Davidson M, et al.: A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry. 1994; 151(3): 390-396.
7. Rasmusson DX, Carson KA, Brookmeyer R, et al.: Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cogn. 1996; 31: 133-147.
8. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al., REAL.FR Group: The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging. 2003; 7: 91-96.
9. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984; 34: 135-146.
10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: APA, 1994.
11. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975; 12: 189-198.
12. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984; 141: 1356-1364.
13. Katz S, Ford AB, Moskowitz RW, et al.: The index of ADL: A standardized measure of biological and psychosocial function. JAMA. 1963; 185: 914-919.
14. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9: 179-186.
15. Cummings JL, Mega M, Gray K, et al.: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44: 2308-2314.
16. Hughes CP, Berg L, Danziger WL, et al.: A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140: 566-572.
17. Vellas B, Guigoz Y, Garry PJ, et al.: The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999; 2: 116-122.
18. Morris JC, Edland S, Clark C, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993; 43: 2457-2465.
19. Lopez OL, Becker JT, Saxton J, et al: Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. J Am Geriatr Soc. 2005; 53: 83-87.
20. Clark CM, Sheppard L, Fillenbaum GG, et al.: Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol. 1999; 56: 857-862.
21. Cortes F, Gillette-Guyonnet S, Nourhashemi F, et al.: Recent data on the natural history of Alzheimer's disease: results from the REAL.FR Study. J Nutr Health Aging. 2005; 9: 86-93.
22. Gillette-Guyonnet S, Cortes F, Cantet C, et al.: Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR Cohort. J Nutr Health Aging. 2005; 9: 69-73.
23. Vellas B, Lauque S, Gillette-Guyonnet S, et al.: Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging. 2005; 9: 75-80.